CMC & Manufacturing Training Courses

Many of our biopharmaceutical training courses offer a free-to-attend Module 1, giving you valuable insights and a preview of the full course experience. Browse the available courses below and register using the form provided. Once registered, you'll receive joining instructions for the live session –...

Many of our regulatory affairs training courses offer a free-to-attend Module 1, giving you valuable insights and a preview of the full course experience. Browse the available courses below and register using the form provided. Once registered, you'll receive joining instructions for the live session...

Many of our pharmaceutical training courses offer a free-to-attend Module 1, giving you valuable insights and a preview of the full course experience. Browse the available courses below and register using the form provided. Once registered, you'll receive joining instructions for the live session –...

A practical introduction to pharmaceutical regulatory affairs, covering what the function does, how medicines move through regulatory systems, the agencies involved, and how professionals build careers in the field. Learn more about our full regulatory affairs training courses - here   What Is Pharmaceutical Regulatory...

Marketing authorisation is a critical step for any medicinal product entering the European market. Unlike the US, where the Food and Drug Administration (FDA) handles approvals, Europe offers several complex regulatory pathways. This article explores the various marketing authorisation routes available in the European Economic…

The pharmaceutical industry is undergoing a fundamental shift in how medicinal product information is managed, exchanged and used. For decades, regulatory processes have been largely document-driven. Product information has been captured within regulatory dossiers, application forms, PDFs and spreadsheets. While initiatives such as the Electronic Common...

In the pharmaceutical industry, quality is not just about meeting specifications or passing inspections. It is about ensuring that every medicine reaching a patient is safe, effective, consistent, and fit for purpose. That responsibility sits at the heart of pharmaceutical quality assurance (QA). Whether manufacturing...

The establishment and management of a comprehensive cell bank system is central to biologics and cell and gene therapy manufacturing. Yet, navigating the requirements, best practices, and regulatory expectations from research through to end-of-production can be complex. In this article, we provide an in-depth look...

In the complex and regulated world of biologics, potency assays are among the most critical tools used to ensure the quality, efficacy, and consistency of therapeutic products. Whether it’s for release testing, stability studies, or development milestones, a robust potency assay is essential. Yet, developing...

  Listen to Educo Life Sciences’ trainer Olivier Negre discuss how the cell & gene therapy sector has changed over the past 10 years and how he expects it to change in the next 10 years. Olivier also discusses the latest increase in gene editing…

Combination products pose regulatory difficulties as the requirements of medical devices must merge with pharmaceuticals and biotech. As biotech and advanced therapeutics grows, so too does the need for specialised device delivery systems resulting in an increase in combination products. Similarly, device companies are increasingly...

The Chemistry, Manufacturing, and Controls (CMC) section of a regulatory dossier is critical in ensuring product quality and regulatory compliance. Educo delivers the course “Completing the Quality/CMC Module of the CTD” which includes a free-to-attend module 1 training session. Over the years, attendees of the...

What does it take to thrive in the ever-evolving world of pharmaceutical R&D? Gareth — a biotech leader, educator, and former translational researcher — has built a unique career across academia, big pharma, and early-stage biotech. In this exclusive interview, he shares how he made...

Drug development is one of the most complex and challenging processes in modern science. Bringing a new medicine from an initial scientific concept to a product that can be prescribed to patients requires years of research, significant investment, and collaboration across multiple disciplines. While the...

In regulated pharmaceutical environments, method validation is a cornerstone of quality assurance. Yet many validated methods still fail to perform reliably in routine use. This disconnection between regulatory compliance and real-world functionality is all too common. The good news? With a more pragmatic and risk-based...

Regulatory lifecycle management is an essential aspect of maintaining product compliance, particularly when dealing with Chemistry, Manufacturing, and Controls (CMC) changes. However, managing these changes on a global scale introduces unique challenges due to differing regulations across countries. In this article, we explore the key…

The Common Technical Document (CTD) is an essential component in pharmaceutical regulatory affairs. It streamlines the submission process across various regions and ensures that drug applications are evaluated efficiently. For professionals working within the pharmaceutical, biopharmaceutical, and regulatory sectors, understanding the structure and functionality of…

Good Manufacturing Practice (GMP) is one of the most critical frameworks governing the pharmaceutical industry. It defines how medicines are manufactured, controlled, documented, and released—ensuring that every product reaching a patient is safe, effective, and consistent. Using the GMP Foundation course transcripts, this article expands...

CMC, Chemistry, Manufacturing and Controls (CMC) refers to all the elements involved in producing pharmaceutical, biologic, or cell & gene products. CMC activities commence from product development and progress through pre-clinical, clinical, and eventual marketing. Various skilled professionals work in CMC to develop and manufacture…

Combination products, which integrate pharmaceutical and medical device components, are an innovative and expanding sector in medical solutions. This article, based on insights from expert Richard Young, covers the unique regulatory challenges faced by manufacturers and developers working with these products, especially in Europe and…

Chemistry, Manufacturing, and Controls (CMC) form a critical component of pharmaceutical drug development. This article delves into the complexities of CMC, discussing its role, processes, and regulatory aspects. This knowledge is essential for professionals involved in drug development, especially in navigating the intricacies of bringing…

Biotech startups face numerous hurdles in Chemistry, Manufacturing, and Controls (CMC) development. From regulatory requirements to balancing costs and timelines, managing these complex processes is crucial for survival in the highly competitive pharmaceutical industry. In this article, we explore key CMC challenges biotech startups face…

Continuous biomanufacturing has rapidly become a vital strategy for pharmaceutical and biotech companies, offering substantial benefits such as cost reduction, faster production timelines, and enhanced process efficiency. Initially introduced in the 1980s, the technology has significantly evolved, now being applied to both upstream and downstream…

Technology transfer (tech transfer) in biopharmaceuticals is a critical process involving the transition of production methods and materials from research and development (R&D) to manufacturing facilities. It ensures that the quality and efficacy of the product are maintained throughout its life cycle, from clinical trials…

A greater number of cell and gene therapies are entering development, often with innovative modalities. One of the biggest challenges is within bioanalytics when understanding biodistribution and pharmacokinetics of cell and gene therapies. As discussed below, a new way of thinking is often required to…

A greater number of cell and gene therapies are entering development, often with innovative modalities. One of the biggest challenges during CMC development is analytics. Analytics of biologics are complex enough, but with cell and gene therapies a new range of analytical issues arise. We...

We interviewed Educo Life Sciences trainer Nadine Ritter to find out why drugs cannot be developed as quick as the COVID vaccine. Nadine explains all the factors that led to the fastest development of a drug in history.   Why Can’t We Develop Products as…

In the fast-paced world of biologics development, analytical assays play a pivotal role in ensuring product safety, efficacy, and regulatory compliance. Yet, despite technological advances, some assays continue to pose significant challenges across the product lifecycle. In a recent conversation with Dr Nadine Ritter, a...

RNA therapeutics have emerged as a pivotal innovation in modern medicine, offering targeted treatments for a range of genetic diseases. Unlike traditional therapies, RNA-based approaches aim to manipulate gene expression or replace faulty proteins, thus providing a powerful tool for combating complex diseases. This article…

Advanced Therapy Medicinal Products (ATMPs) represent a cutting-edge category of treatments in the pharmaceutical industry, designed to address unmet medical needs, particularly for complex and chronic conditions. These therapies fall under four broad categories: gene therapies, somatic-cell therapies, tissue-engineered products, and combined ATMPs. This article…

Getting a cell and gene therapy developed, manufactured, and approved on the market is challenging. There are numerous hurdles to overcome such as supply chain issues, aseptic working, patient access, efficacy and safety.  Below are short interviews with a range of Educo Life Science Trainers…

The cell and gene therapy (ATMPs) industry has grown significantly. The number of therapies reaching clinical trials and market approval has increased. To fuel its growth, a skilled workforce is required in all areas of development such as regulatory, clinical, manufacturing (process), analytical and commercialisation….

In this interview, Sophie, an experienced professional in pharmaceutical regulatory affairs, shares her career journey, the evolution of the industry, and advice for those starting in the field. With over 22 years of experience, Sophie offers valuable insights for professionals interested in Chemistry, Manufacturing, and…

The field of bioassays is critical to the development of biologics — from understanding drug behaviour to monitoring safety and efficacy. But it’s also a space many scientists find themselves in unexpectedly, without clear pathways or preparation. We spoke with Melody, a bioanalytical expert and...

Getting started in EU regulatory affairs can feel daunting — especially if you're a recent graduate with little exposure to the pharmaceutical industry. We spoke with Adriaan, a seasoned regulatory affairs professional and Educo Life Sciences trainer, about how he entered the field, the challenges...

Regulatory Affairs (RA) is often described as a compliance function, but in practice it plays a far broader and more strategic role across pharmaceutical and biotechnology development. Regulatory professionals sit at the intersection of science, law, and business—ensuring that medicines are developed responsibly, approved efficiently,...

Navigating Module 3 of the Common Technical Document (CTD) is crucial for any regulatory affairs professional. This module, the quality section, presents the foundation of Chemistry, Manufacturing, and Controls (CMC) data that demonstrate the suitability, safety, and efficacy of a pharmaceutical product. From a practical…

Regulatory affairs (RA) is an integral part of the life sciences industry, bridging the gap between pharmaceutical, biotech, and medical device companies and regulatory bodies. For those considering a career in this field or looking to advance, understanding the right entry points, necessary skills, and…

We interviewed Educo Life Sciences trainer John Faulkes to discuss a career in pharmaceuticals for those who are not scientists. We often get asked the best routes to get into the pharmaceutical industry and John highlights alternative routes that are perfect for non-scientists. In this…